"The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

Clinical testing remained the leading application segment in 2024. The lateral flow assays market is expected to reach ...

In the new COVID test, it is the binding of the SARS-CoV-2 spike protein to a metallic substrate that triggers the ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

York-based lateral flow test specialist Abingdon Health has revealed it has five new development projects under way in the US ...

The global lateral flow assay market is estimated at USD 8.2 billion in 2024 and is projected to reach USD 12.6 billion by 2030, expected to grow at a CAGR of 7.5% during the forecast period, ...

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

The US Food and Drug Administration issued marketing clearances for antimicrobial susceptibility tests, respiratory infection tests, and a cardiac troponin test, among others.

You can exhibit COVID-19 symptoms yet test negative due to early infection, low viral load, or immune response. PCR testing ...

The Sustainable Control of Parasites in Sheep (SCOPS) is pleased to announce the third instalment in series three of its popular podcasts. As the trend towards drier, hotter summers and warmer, wetter ...

(Alliance News) - Abingdon Health PLC on Monday reported progress at Abingdon Health USA Inc, with five projects currently underway at its facilities in Madison, Wisconsin. Shares in the York, England ...